Company: DVAX
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001029142-25-000071
Chunk: 269

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 8
Chunk 269
---
, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows (in thousands): March 31,2025December 31,2024March 31,2024December 31,2023Cash and cash equivalents$51,720 $95,883 $132,033 $150,279 Restricted cash (1)281 271 271 277 Total cash and cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows$52,001 $96,154 $132,304 $150,556 (1)Restricted cash is included in "Other assets" in the Condensed Consolidated Balance Sheets.Restricted cash balances relate to certificates of deposit issued as collateral to certain letters of credit issued as security to our lease arrangements (see Note 5).

11

Table of Contents

Cash and cash equivalents, and marketable securities consist of the following (in thousands):AmortizedCostUnrealizedGainsUnrealizedLosses EstimatedFair ValueMarch 31, 2025Cash and cash equivalents:Cash$11,993 $- $- $11,993 Money market funds39,727 - - 39,727 Total cash and cash equivalents51,720 - - 51,720 Marketable securities available-for-sale:     U.S. treasuries263,030 635 (125)263,540 U.S. government agency securities144,276 353 (91)144,538 Corporate debt securities201,345 305 (112)201,538 Total marketable securities available-for-sale608,651 1,293 (328)609,616 Total cash and cash equivalents, and marketable securities$660,371 $1,293 $(328)$661,336 December 31, 2024Cash and cash equivalents:Cash$12,157 $- $- $12,157 Money market funds83,726 - - 83,726 Total cash and cash equivalents95,883 - - 95,883 Marketable securities available-for-sale:     U.S. treasuries199,741 460 (322)199,879 U.S. government agency securities158,605 486 (220)158,871 Corporate debt securities259,004 418